Knowledge Center

Patent / Jan 11, 2024

Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation

Authors:
  • Beatriz Fernandes
  • Filipe Vultos
  • Eunice Costa
Source:
WO 2024009079 A1

The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.

Ìý

Also in the Knowledge Center

Related Content

Potent compounds

Safety first

Page
Read more

Devices

ËÄÉ«AV offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more

PowdAir® DPI

Easy-to-use, multi-use capsule DPI.

Page
Read more